S3K-17663-73730
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Health check-in — day 0, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-07
- 2021-10-16
- 2021-10-21
- 2021-10-30
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Headache, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid infection fever, cough, sore throat, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 12 months, dose 3
Symptoms: Covid infection fever, cough, sore throat, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release